Literature DB >> 15039519

Assembly of Marek's disease virus (MDV) capsids using recombinant baculoviruses expressing MDV capsid proteins.

E Kut1, D Rasschaert1.   

Abstract

The genes UL18, UL19, UL26, UL26.5, UL35 and UL38 of Marek's disease virus 1 (MDV-1) strain RB1B, encoding the homologues of herpes simplex virus type 1 (HSV-1) capsid proteins VP23, VP5, VP21-VP24, preVP22a, VP26 and VP19C, were identified and sequenced. Recombinant baculoviruses were used to express the six capsid genes in insect cells. Coexpression of the six genes or of UL18, UL19, UL26.5 and UL38 in insect cells resulted in the formation of capsids with a large core. In addition, electron microscopy of thin sections clearly revealed the presence of large numbers of small spherical particles. Experimental coinfection demonstrated that these small particles were associated with production of the preVP22a protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039519     DOI: 10.1099/vir.0.19725-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Sequential autoprocessing of Marek's disease herpesvirus protease differs from that of other herpesviruses.

Authors:  S Laurent; C Blondeau; M Belghazi; S Remy; E Esnault; P Rasschaert; D Rasschaert
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

2.  Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection.

Authors:  Vaishali Chaudhuri; Marvin Sommer; Jaya Rajamani; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

3.  Self-assembly of Epstein-Barr virus capsids.

Authors:  Brandon W Henson; Edward M Perkins; Jonathan E Cothran; Prashant Desai
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

Review 4.  Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.

Authors:  Stanislav Sokolenko; Steve George; Andreas Wagner; Anup Tuladhar; Jonas M S Andrich; Marc G Aucoin
Journal:  Biotechnol Adv       Date:  2012-01-28       Impact factor: 14.227

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.